CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Open-market sale Chief Commercial Officer sold 11,269 shares at $0.94 ($10,593)
- 4 Open-market sale Chief Financial Officer sold 35,000 shares at $0.90 ($31,500)
- 8-K Event Other events
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Open-market sale Chief Commercial Officer sold 25,000 shares at $0.73 ($18,250)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Agreement ended
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Executive Officer sold 71,519 shares at $0.83 ($59,361)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Commercial Officer sold 10,000 shares at $0.81 ($8,100)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Commercial Officer sold 10,000 shares at $0.72 ($7,200)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Agreement ended
- 8-K Event Regulation FD disclosure
Page 15 of 28 · 547 filings